文献速递眼底病与葡萄膜炎眼整形与眼眶

结膜原发性获得性黑变病/黑色素瘤:结膜地图活检的效用

Primary acquired melanosis/melanoma: utility of conjunctival map biopsy.
PubMed 文献 · Br J Ophthalmol · 2020-12-18

该回顾性病例系列纳入51例结膜原发性获得性黑变病(PAM)/黑色素瘤患者,共分析400份活检样本(55份诊断性活检、345份地图活检)。地图活检使6例(11%)检出重度异型性并接受局部丝裂霉素治疗,3份临床阴性/病理阳性样本诊断为无色素性PAM。

要点

  • 地图活检可明确病变解剖与病理范围,影响辅助局部化疗决策。
  • 地图活检检出6例(11%)重度异型性,需局部丝裂霉素治疗。
  • 无地图活检则无法诊断无色素性PAM(3份临床阴性/病理阳性)。

核心结论

  • 地图活检增强了对结膜PAM/黑色素瘤解剖和病理范围的总体评估,并影响辅助局部化疗的使用。
  • 若无地图活检,将无法诊断无色素性PAM。

研究设计与样本

  • 回顾性病例系列,纳入51例独特患者的400份结膜活检样本(55份诊断性活检、345份地图活检),来自三级转诊中心。
  • 每例患者接受1次诊断性活检和若干次额外地图活检(范围2-7次)。

主要发现

  • 中位年龄63岁(范围20-88),女性占67%。
  • 组织病理学分级为0级(黑色素变阴性/正常)至4级(浸润性黑色素瘤)。
  • 多数地图活检(313份,91%)显示临床病理一致:阳性为临床+/病理+(57份,17%),阴性为临床-/病理-(256份,74%)。
  • 3份不一致样本(临床-/病理+)代表无色素性PAM。
  • 多数病例异型性谱缺失(40例,73%)或局限(11例,20%),倾向聚集为低级别或高级别异型性。

关键数值与推荐

  • 组织病理学分级:0级为黑色素变阴性/正常,1级为无异性型性的黑色素变,2级为轻度异型性黑色素变,3级为重度异型性黑色素变,4级为浸润性黑色素瘤。
  • 地图活检检出6例(11%)重度异型性并接受局部MMC;29例建议定期观察。

临床怎么用

  • 对结膜PAM/黑色素瘤患者行地图活检以评估病变范围和异型性程度,指导是否使用局部丝裂霉素等辅助化疗。
  • 地图活检有助于识别无色素性PAM,避免漏诊。

局限性

  • 本研究为回顾性病例系列,需额外验证性工作以证实观察结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To assess the role of map biopsy in patients with conjunctival primary acquired melanosis (PAM)/melanoma. METHODS: Retrospective case series of 400 conjunctival biopsy samples of 51 unique patients in a tertiary referral centre. RESULTS: Each patient underwent one diagnostic biopsy and several additional map biopsies (range 2-7) providing a total of 400 samples for the analysis (55 diagnostic biopsies, 345 map biopsies). The median age was 63 years old (range 20-88) with women representing 67% of the cases. Histopathological findings were graded as negative for melanosis/normal (grade 0), melanosis without atypia (grade 1), melanosis with mild atypia (grade 2), melanosis with severe atypia (grade 3) or invasive melanoma (grade 4). Clinicopathologic concordance was observed in the majority of the map biopsies (313, 91%) (positive: clinical+/path+ (57,17%), negative: clinical-/path- (256, 74%)). Three discordant samples (clinical-/path+) represented PAM sine pigmento. The histopathological spectrum of atypia was absent (40, 73%) or limited (11, 20%) in the majority of cases with tendency to cluster as low-grade or high-grade atypia. Map biopsy led to the identification of six patients (11%) with severe atypia, requiring topical mitomycin (MMC). Similarly, in 29 cases, periodic observation without topical MMC was recommended. One case of invasive melanoma transformation occurred in the MMC-treated group. CONCLUSIONS: Map biopsy enhances overall assessment of the anatomic and pathologic extent, impacting use of adjuvant topical chemotherapy. In absence of map biopsy, it would be impossible to diagnose PAM sine pigmento. Additional corroborative work is needed to validate our observations.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Soto H, Bowen RC, Raval V, et al. Primary acquired melanosis/melanoma: utility of conjunctival map biopsy. Br J Ophthalmol. 2020. PMID: 33355161. doi:10.1136/bjophthalmol-2020-317772

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。